Track structure simulation for positron emitters of physical interest. Part III: The case of the non-standard radionuclides

With the growth of clinical Positron Emission Tomography (PET) utilizations, new molecular tracers, able to aid in the assessment, therapy planning and monitoring of cancer patients, are synthesized. As suggested by some works reported in the literature, these newcomers may be positron emitting isotopes of lanthanium, 134La, iodine, 120I, 121I and 124I, arsenic, 72As and 74As, oxygen, 14O, and neon, 19Ne. s work, we present an inter comparison of these eight radiopharmaceuticals which may be used in PET. To do that we have used a Monte Carlo simulation of positron following-up in water that we have adapted to the beta decay of radionuclides. e also access to accurate spatial and energetic distributions of the potential PET radiopharmaceuticals under investigation here. The results are given in an analytical way and have been compared, when possible, with theoretical and experimental values available in the literature.